Mirae Asset Global Investments Co., Ltd. Centessa Pharmaceuticals PLC Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,730 shares of CNTA stock, worth $28,164. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,730Holding current value
$28,164% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding CNTA
# of Institutions
83Shares Held
96.6MCall Options Held
12.1KPut Options Held
3K-
Medicxi Ventures Management (Jersey) LTD20MShares$325 Million64.35% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$162 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$158 Million2.77% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.71MShares$93 Million1.82% of portfolio
-
First Light Asset Management, LLC Edina, MN4.78MShares$77.8 Million3.93% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.54B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...